342 related articles for article (PubMed ID: 2533050)
1. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
Jones RN; Barry AL; Gardiner RV; Packer RR
Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
[TBL] [Abstract][Full Text] [Related]
3. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
Tabe Y; Nakamura A; Igari J
J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
Bannerman TL; Wadiak DL; Kloos WE
Antimicrob Agents Chemother; 1991 Sep; 35(9):1919-22. PubMed ID: 1835340
[TBL] [Abstract][Full Text] [Related]
5. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Mashaly GE; El-Mahdy RH
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
[TBL] [Abstract][Full Text] [Related]
7. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
Low DE; McGeer A; Poon R
Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
Jansen B; Schumacher-Perdreau F; Pulverer G
Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
[TBL] [Abstract][Full Text] [Related]
9. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
[TBL] [Abstract][Full Text] [Related]
10. Low-level resistance to glycopeptides amongst staphylococcus species: surveillance in a university hospital and evaluation of a vancomycin screening agar.
Park YJ; Jun Park J; Lee SO; Oh EJ; Kee Kim B
Diagn Microbiol Infect Dis; 2001 Nov; 41(3):155-9. PubMed ID: 11750170
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibilities of four species of coagulase-negative staphylococci.
Fass RJ; Helsel VL; Barnishan J; Ayers LW
Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
[TBL] [Abstract][Full Text] [Related]
13. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
Chaudhury A; Kumar AG
Indian J Med Microbiol; 2007 Jan; 25(1):50-2. PubMed ID: 17377353
[TBL] [Abstract][Full Text] [Related]
15. Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.
Jones RN; Goldstein FW; Zhou XY
Antimicrob Agents Chemother; 1991 Mar; 35(3):584-6. PubMed ID: 1828137
[TBL] [Abstract][Full Text] [Related]
16. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
17. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of a European collaborative study on comparative susceptibility of gram-positive clinical isolates to teicoplanin and vancomycin.
Grüneberg RN; Hryniewicz W
Int J Antimicrob Agents; 1998 Nov; 10(4):271-7. PubMed ID: 9916900
[TBL] [Abstract][Full Text] [Related]
19. Glycopeptide resistance in coagulase-negative staphylococci.
Biavasco F; Vignaroli C; Varaldo PE
Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
[TBL] [Abstract][Full Text] [Related]
20. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
